AARC 2019 Corporate Partners
Corporate Partner Program is comprised of best-in-class organizations interested in supporting the goals and work of the Association. The program aims to give respiratory care providers information, insights, and innovative approaches to improve performance and advance the health of their patients. Together, this move will strengthen each of us in all of our endeavors. It is with great pride that we present our Corporate Partners.
Fisher & Paykel Healthcare is a leading designer, manufacturer and marketer of products and systems for use in respiratory care, acute care, and the treatment of obstructive sleep apnea.
Our products and systems are sold in over 120 countries worldwide. We sell our products through direct sales offices operations in most of our major markets, and a network of distributors that sell to hospitals, homecare providers and other manufacturers of medical devices.
Fisher & Paykel entered the respiratory care market in 1971 with the development of a unique respiratory humidifier system for use in critical care. We now offer a broad range of products and systems for use in respiratory and acute care and in the treatment of obstructive sleep apnea (OSA). For more information, visit www.fphcare.com.
Hamilton Medical is a leader in mechanical ventilation for respiratory therapy offering intelligent ventilation solutions for all patient populations in the intensive care unit, in the emergency department, during an MRI procedure, or in any transport situation in or outside the hospital. For more information visit www.hamilton-medical.com.
Mallinckrodt is a global specialty biopharmaceutical business that develops, manufactures, markets and distributes specialty pharmaceutical products and medical imaging agents. A key product within the company’s Specialty Brands segment is INOMAX®, which is offered through the INOMAX Total Care® package, an all-inclusive offering of drug, drug-delivery system, on-site training, emergency deliveries and 24/7/365 technical assistance and support. To learn more, visit www.inomax.com.
Masimo, innovator and leader of motion and low perfusion tolerant pulse oximetry, a technology that non invasively measures arterial oxygen saturation, is committed to improving patient outcomes and reducing cost of care by working with dedicated hospital staff to convert health care institutions around the world to Masimo SET pulse oximetry technology. They are accomplishing this goal by directly marketing complete pulse oximetry solutions to hospitals, as well as by partnering with patient monitoring companies to create innovative, cost-effective acquisition programs for Masimo SET products. Masimo Corporation is located in Irvine, California.
Medtronic, a global leader in medical technology, is contributing to human welfare by application of biomedical engineering in the research, design, manufacture, and sale of instruments or appliances that alleviate pain, restore health, and extend life. Medtronic is redefining how technology is used in the management of chronic disease. A deep understanding of human physiology yields unique insight into a range of therapeutic areas, including heart and vascular diseases, diabetes, neurological disorders, and spinal conditions. This breadth of offerings, combined with years of experience, allows Medtronic to deliver therapies that are transforming the treatment of chronic disease and changing the lives of more than 7 million patients worldwide each year.
Monaghan Medical Corporation (MMC) is a leader in the development and manufacture of aerosol drug delivery devices and asthma management products. Monaghan is a supplier to major pharmaceutical companies in respiratory medicine in the United States. The company’s strength lies in product development around core capabilities in mechanical design complimented by collaboration with a state-of-the-art aerosol research laboratory. Monaghan is focused on developing cost-efficient, outcome-based solutions for our customers.
Monaghan is dedicated to the pursuit of respiratory airway solutions for care providers and patients. Over 300 peer-reviewed articles supporting the company’s respiratory management products have been published in medical journals throughout the world.
Sunovion is a global biopharmaceutical company focused on the innovative application of science and medicine to help people with serious medical conditions. Sunovion’s vision is to lead the way to a healthier world. The company’s spirit of innovation is driven by the conviction that scientific excellence paired with meaningful advocacy and relevant education can improve lives. With patients at the center of everything it does, Sunovion has charted new paths to life-transforming treatments that reflect ongoing investments in research and development and an unwavering commitment to support people with psychiatric, neurological and respiratory conditions. For more information visit www.sunovion.us
Vapotherm is the leader and inventor of High Velocity Nasal Insufflation (HVNI), a mask-free form of noninvasive ventilation for spontaneously breathing patients. Vapotherm Hi-VNI® Technology is a fast and safe approach to relieve hypercapnia, hypoxemia, and dyspnea. For more information visit www.vapotherm.com.
The Boehringer Ingelheim group is one of the world’s 20 leading pharmaceutical companies. Headquartered in Ingelheim, Germany, it operates globally with 145 affiliates and more than 44,000 employees. Since it was founded in 1885, the family-owned company has been committed to researching, developing, manufacturing and marketing novel medications of high therapeutic value for human and veterinary medicine. Follow us on Twitter at http://twitter.com/boehringerus.